 | • レポートコード：QYR2104Z4637 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、形質細胞新生物治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、生物学的製剤、標的療法）、用途別市場規模（病院、専門クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・形質細胞新生物治療の市場動向 ・企業の競争状況、市場シェア ・形質細胞新生物治療の種類別市場規模（放射線療法、化学療法、生物学的製剤、標的療法） ・形質細胞新生物治療の用途別市場規模（病院、専門クリニック、外来手術センター） ・形質細胞新生物治療の北米市場規模2016-2027（アメリカ、カナダ） ・形質細胞新生物治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・形質細胞新生物治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・形質細胞新生物治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・形質細胞新生物治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Amgen、Bristol-Myers Squibb、Celgene、Janssen Biotech、Millennium Pharmaceutical、Novartis、Spectrum Pharmaceutical、Sun Pharmaceutical Industries） ・結論 |
Plasma cell neoplasms are diseases in which the body makes too many plasma cells.
The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken or can damage the kidneys.
Market Analysis and Insights: Global Plasma Cell Neoplasm Treatment Market
The global Plasma Cell Neoplasm Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasma Cell Neoplasm Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasma Cell Neoplasm Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasma Cell Neoplasm Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasma Cell Neoplasm Treatment market.
Global Plasma Cell Neoplasm Treatment Scope and Market Size
Plasma Cell Neoplasm Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Cell Neoplasm Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Radiation Therapy
Chemotherapy
Biologics or Targeted Therapy
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie
Amgen
Bristol-Myers Squibb
Celgene
Janssen Biotech
Millennium Pharmaceutical
Novartis
Spectrum Pharmaceutical
Sun Pharmaceutical Industries
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Cell Neoplasm Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Biologics or Targeted Therapy
1.3 Market by Application
1.3.1 Global Plasma Cell Neoplasm Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasma Cell Neoplasm Treatment Market Perspective (2016-2027)
2.2 Plasma Cell Neoplasm Treatment Growth Trends by Regions
2.2.1 Plasma Cell Neoplasm Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasma Cell Neoplasm Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Plasma Cell Neoplasm Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Plasma Cell Neoplasm Treatment Industry Dynamic
2.3.1 Plasma Cell Neoplasm Treatment Market Trends
2.3.2 Plasma Cell Neoplasm Treatment Market Drivers
2.3.3 Plasma Cell Neoplasm Treatment Market Challenges
2.3.4 Plasma Cell Neoplasm Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Cell Neoplasm Treatment Players by Revenue
3.1.1 Global Top Plasma Cell Neoplasm Treatment Players by Revenue (2016-2021)
3.1.2 Global Plasma Cell Neoplasm Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Plasma Cell Neoplasm Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasma Cell Neoplasm Treatment Revenue
3.4 Global Plasma Cell Neoplasm Treatment Market Concentration Ratio
3.4.1 Global Plasma Cell Neoplasm Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Cell Neoplasm Treatment Revenue in 2020
3.5 Plasma Cell Neoplasm Treatment Key Players Head office and Area Served
3.6 Key Players Plasma Cell Neoplasm Treatment Product Solution and Service
3.7 Date of Enter into Plasma Cell Neoplasm Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Cell Neoplasm Treatment Breakdown Data by Type
4.1 Global Plasma Cell Neoplasm Treatment Historic Market Size by Type (2016-2021)
4.2 Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Type (2022-2027)
5 Plasma Cell Neoplasm Treatment Breakdown Data by Application
5.1 Global Plasma Cell Neoplasm Treatment Historic Market Size by Application (2016-2021)
5.2 Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Plasma Cell Neoplasm Treatment Market Size (2016-2027)
6.2 North America Plasma Cell Neoplasm Treatment Market Size by Type
6.2.1 North America Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021)
6.2.2 North America Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027)
6.2.3 North America Plasma Cell Neoplasm Treatment Market Size by Type (2016-2027)
6.3 North America Plasma Cell Neoplasm Treatment Market Size by Application
6.3.1 North America Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021)
6.3.2 North America Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027)
6.3.3 North America Plasma Cell Neoplasm Treatment Market Size by Application (2016-2027)
6.4 North America Plasma Cell Neoplasm Treatment Market Size by Country
6.4.1 North America Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021)
6.4.2 North America Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Plasma Cell Neoplasm Treatment Market Size (2016-2027)
7.2 Europe Plasma Cell Neoplasm Treatment Market Size by Type
7.2.1 Europe Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021)
7.2.2 Europe Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027)
7.2.3 Europe Plasma Cell Neoplasm Treatment Market Size by Type (2016-2027)
7.3 Europe Plasma Cell Neoplasm Treatment Market Size by Application
7.3.1 Europe Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021)
7.3.2 Europe Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027)
7.3.3 Europe Plasma Cell Neoplasm Treatment Market Size by Application (2016-2027)
7.4 Europe Plasma Cell Neoplasm Treatment Market Size by Country
7.4.1 Europe Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021)
7.4.2 Europe Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size (2016-2027)
8.2 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Type
8.2.1 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Application
8.3.1 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Region
8.4.1 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasma Cell Neoplasm Treatment Market Size (2016-2027)
9.2 Latin America Plasma Cell Neoplasm Treatment Market Size by Type
9.2.1 Latin America Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Plasma Cell Neoplasm Treatment Market Size by Type (2016-2027)
9.3 Latin America Plasma Cell Neoplasm Treatment Market Size by Application
9.3.1 Latin America Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Plasma Cell Neoplasm Treatment Market Size by Application (2016-2027)
9.4 Latin America Plasma Cell Neoplasm Treatment Market Size by Country
9.4.1 Latin America Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size (2016-2027)
10.2 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Type
10.2.1 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Application
10.3.1 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Country
10.4.1 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Plasma Cell Neoplasm Treatment Introduction
11.1.4 AbbVie Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Plasma Cell Neoplasm Treatment Introduction
11.2.4 Amgen Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Plasma Cell Neoplasm Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Plasma Cell Neoplasm Treatment Introduction
11.4.4 Celgene Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Details
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Plasma Cell Neoplasm Treatment Introduction
11.5.4 Janssen Biotech Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.5.5 Janssen Biotech Recent Development
11.6 Millennium Pharmaceutical
11.6.1 Millennium Pharmaceutical Company Details
11.6.2 Millennium Pharmaceutical Business Overview
11.6.3 Millennium Pharmaceutical Plasma Cell Neoplasm Treatment Introduction
11.6.4 Millennium Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.6.5 Millennium Pharmaceutical Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Plasma Cell Neoplasm Treatment Introduction
11.7.4 Novartis Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Spectrum Pharmaceutical
11.8.1 Spectrum Pharmaceutical Company Details
11.8.2 Spectrum Pharmaceutical Business Overview
11.8.3 Spectrum Pharmaceutical Plasma Cell Neoplasm Treatment Introduction
11.8.4 Spectrum Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.8.5 Spectrum Pharmaceutical Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Details
11.9.2 Sun Pharmaceutical Industries Business Overview
11.9.3 Sun Pharmaceutical Industries Plasma Cell Neoplasm Treatment Introduction
11.9.4 Sun Pharmaceutical Industries Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Plasma Cell Neoplasm Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Biologics or Targeted Therapy
Table 5. Global Plasma Cell Neoplasm Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Plasma Cell Neoplasm Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Plasma Cell Neoplasm Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Plasma Cell Neoplasm Treatment Market Share by Regions (2016-2021)
Table 9. Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Plasma Cell Neoplasm Treatment Market Share by Regions (2022-2027)
Table 11. Plasma Cell Neoplasm Treatment Market Trends
Table 12. Plasma Cell Neoplasm Treatment Market Drivers
Table 13. Plasma Cell Neoplasm Treatment Market Challenges
Table 14. Plasma Cell Neoplasm Treatment Market Restraints
Table 15. Global Plasma Cell Neoplasm Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Plasma Cell Neoplasm Treatment Market Share by Players (2016-2021)
Table 17. Global Top Plasma Cell Neoplasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Cell Neoplasm Treatment as of 2020)
Table 18. Ranking of Global Top Plasma Cell Neoplasm Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Plasma Cell Neoplasm Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Plasma Cell Neoplasm Treatment Product Solution and Service
Table 22. Date of Enter into Plasma Cell Neoplasm Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Plasma Cell Neoplasm Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Plasma Cell Neoplasm Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie Plasma Cell Neoplasm Treatment Product
Table 65. AbbVie Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Plasma Cell Neoplasm Treatment Product
Table 70. Amgen Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Plasma Cell Neoplasm Treatment Product
Table 75. Bristol-Myers Squibb Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Celgene Company Details
Table 78. Celgene Business Overview
Table 79. Celgene Plasma Cell Neoplasm Treatment Product
Table 80. Celgene Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 81. Celgene Recent Development
Table 82. Janssen Biotech Company Details
Table 83. Janssen Biotech Business Overview
Table 84. Janssen Biotech Plasma Cell Neoplasm Treatment Product
Table 85. Janssen Biotech Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 86. Janssen Biotech Recent Development
Table 87. Millennium Pharmaceutical Company Details
Table 88. Millennium Pharmaceutical Business Overview
Table 89. Millennium Pharmaceutical Plasma Cell Neoplasm Treatment Product
Table 90. Millennium Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 91. Millennium Pharmaceutical Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Plasma Cell Neoplasm Treatment Product
Table 95. Novartis Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Spectrum Pharmaceutical Company Details
Table 98. Spectrum Pharmaceutical Business Overview
Table 99. Spectrum Pharmaceutical Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 100. Spectrum Pharmaceutical Recent Development
Table 101. Sun Pharmaceutical Industries Company Details
Table 102. Sun Pharmaceutical Industries Business Overview
Table 103. Sun Pharmaceutical Industries Plasma Cell Neoplasm Treatment Product
Table 104. Sun Pharmaceutical Industries Revenue in Plasma Cell Neoplasm Treatment Business (2016-2021) & (US$ Million)
Table 105. Sun Pharmaceutical Industries Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Cell Neoplasm Treatment Market Share by Type: 2020 VS 2027
Figure 2. Radiation Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Biologics or Targeted Therapy Features
Figure 5. Global Plasma Cell Neoplasm Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Plasma Cell Neoplasm Treatment Report Years Considered
Figure 10. Global Plasma Cell Neoplasm Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Plasma Cell Neoplasm Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Plasma Cell Neoplasm Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Plasma Cell Neoplasm Treatment Market Share by Regions (2022-2027)
Figure 14. Global Plasma Cell Neoplasm Treatment Market Share by Players in 2020
Figure 15. Global Top Plasma Cell Neoplasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Cell Neoplasm Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Plasma Cell Neoplasm Treatment Revenue in 2020
Figure 17. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Plasma Cell Neoplasm Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Plasma Cell Neoplasm Treatment Market Share by Type (2016-2027)
Figure 21. North America Plasma Cell Neoplasm Treatment Market Share by Application (2016-2027)
Figure 22. North America Plasma Cell Neoplasm Treatment Market Share by Country (2016-2027)
Figure 23. United States Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Plasma Cell Neoplasm Treatment Market Share by Type (2016-2027)
Figure 27. Europe Plasma Cell Neoplasm Treatment Market Share by Application (2016-2027)
Figure 28. Europe Plasma Cell Neoplasm Treatment Market Share by Country (2016-2027)
Figure 29. Germany Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Plasma Cell Neoplasm Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Plasma Cell Neoplasm Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Plasma Cell Neoplasm Treatment Market Share by Region (2016-2027)
Figure 39. China Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Plasma Cell Neoplasm Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Plasma Cell Neoplasm Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Plasma Cell Neoplasm Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Plasma Cell Neoplasm Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Plasma Cell Neoplasm Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Plasma Cell Neoplasm Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Plasma Cell Neoplasm Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 59. Amgen Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 61. Celgene Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 62. Janssen Biotech Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 63. Millennium Pharmaceutical Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 65. Spectrum Pharmaceutical Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 66. Sun Pharmaceutical Industries Revenue Growth Rate in Plasma Cell Neoplasm Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilica…- 世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
- 世界の犬幹細胞療法市場規模・現状・予測（2021年-2027年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年） Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …
- 世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…